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Discussion
Mr Cliff K. Choong (Cambridge, United Kingdom). Congratula-
tions on your very good study and results. Based on this, have you
changed your practice to use this device for all your subsequent
patients?
Dr Corno. First of all, we now can use this device in any
patient because the hospital administration is convinced that, de-
spite the initial cost, we can spare the money.
Regarding the management, we changed a lot of policies. For
instance, patients with multiple ventricular septal defects are now,
in the neonatal period, treated with this device. Now we have a
group of 5 patients, on average 2 to 3 years after surgical inter-
vention, and we follow all of them. Of course, when the patient
grows and the body weight increases, we can release the device to
avoid the right ventricular pressure becoming suprasystemic. And
in 4 patients all multiple ventricular septal defects, 2½ to 3 years
after surgical intervention, underwent spontaneous closure. Two
weeks ago, I operated on one patient, removing the device, and
without anything else required, even the pulmonary artery recon-
struction was not necessary. Much easier is the management, of
course, of a univentricular heart, for obvious reasons, because you
can titrate the distal pulmonary artery pressure as you want based
on echocardiographic results. In the group for left ventricular
retraining, we have only 4 patients, but the number is increasing
and, of course, in the future, with this device available for left
ventricular retraining.
Mr Choong. Second, do you recommend that all pediatric
surgeons should now be using this rather than conv-PAB?
Dr Corno. Yes. It changes from the night to the day.
Mr Choong. Lastly, the device seems to be flawless. Are there
any short- or long-term complications associated with this device?
Dr Corno. We have found complications with this device
caused by the fact that the piston is covered by a silicone mem-
brane to prevent damage to the pulmonary artery. We had one
complication in one of the animals in the clinical study and in 2
patients, one in another center and one in our center, because if you
go close to the membrane with any sharp instrument, like a needle
or knife, you can produce a hole in the membrane, the pericardial
fluid enters into the device, and then the micromotor stops work-
ing. Then you remain with a conventional banding.
Dr Renato Assad (Sao Paulo, Brazil). First of all, I would like
to congratulate Dr Corno and his colleagues for the very ingenious
FloWatch and his work on adjustable PAB.
I would like to share with the association the first case in which
a high-risk neonate with hypoplastic left heart syndrome was
initially managed with a miniadjustable PAB system in both pul-
monary arteries. The banding system is entirely silicone covered,
a miniaturized and improved device developed from our previous
experimental studies that resulted in a more delicate banding
system for neonatal use with a 4-mm diameter. Ten percutaneous
adjustments of the banding system were necessary to keep the
arterial oxygen saturation in the 75 to 85 range before the second
stage. The Norwood operation and bidirectional Glenn shunt were
carried out on the 106th day of life, and the total cavopulmonary
connection was carried out in the 21st month of life. There was no
pulmonary artery distortion after removing the bands.
The clinical use of this innovative PAB system allowed for a
customization of the pulmonary blood flow according to the un-
derlying clinical needs, resulting in a more precise balance be-
tween the pulmonary and systemic circulations.
I have a question for Dr Corno regarding the left ventricular
retraining patient. How was the length of time comparing the 2
systems?
I thank the association for the opportunity to make these
comments about your new prototype.
Dr Corno. Thank you, Dr Assad, for the question. Of course I
am familiar with your article, and I can tell you at the moment that
there is no indication of using this device when you need a bilateral
banding. The first reason is the size of the device, and the second
is the cost. You will need to do another study and have discussions
with the hospital administrators.
To answer your question, the interval depends on the adapt-
ability of the new system. We follow this with echocardiography,
and we want, of course, to obtain almost systemic pressure in the
new systemic ventricle. From a study done when I was in Lau-
sanne,11 we calculated with the echocardiographic analysis the
ratio between the thickness of the free wall of the right ventricle
versus the left ventricle. When you have reached the inversion of
the ratio, it means that we have reached a high enough level of left
ventricular hypertrophy or hyperplasia according to the age of the
child, and then we can go for the arterial switch operation.
Dr Pedro Becker (Santiago, Chile). That was very interesting,
Antonio, but what bothers me is that I do not find here the key end
point that you are pursuing when you band the pulmonary artery.
To me, mortality is such a gross end point. Pulmonary artery bands
are designed to either decrease pulmonary artery pressure, limit
Qp/Qs, or retrain the left ventricle. Therefore I think it would be
very interesting to really know whether the goals of the PAB were
properly accomplished with this device in a better way than the
conventional technique and therefore convince us surgeons not to
use just the regular PAB any more. Congratulations, anyway.
Dr Corno. Thank you. First of all, you can discuss the
indication for banding versus repair. These patients, in our
experience, were without indication for a repair because either
they were in for a univentricular type of repair (and you cannot
perform a cavopulmonary connection in the first weeks of life)
or in for left ventricular retraining. In case of biventricular
repair, we had patients with unbalanced complete atrioventric-
ular septal defect, multiple ventricular septal defects, ventricu-
lar septal defect with aortic coarctation, and hypoplasia of the
aortic arch. Most patients were referred after 1 or 2 months in
the ICU on mechanical ventilation. In our experience these
patients did not constitute a good indication for banding. Then
you have to decide between a conventional banding and an
adjustable banding. The main difference is the management in
the immediate postoperative course.
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With a fixed band, either you have to go back and reopen the chest
2 or 3 times, particularly when you need for univentricular heart or left
ventricular retraining, whereas with this device you can simply go in
the operating room, perform a much faster procedure, and clip the
band and close the chest, and you do all the adjustments after the
operation. You can do it progressively within days or weeks, and this
is much better tolerated than the conventional banding, when you
have to suddenly change the hemodynamics.
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